OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
60398755

Shanghai Kindly Enterprise Development Group Co Ltd

Medical Equipment, Supplies & DistributionVerified

Shanghai Kindly Enterprise Development Group Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.21, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.77, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow stands at 190.76 million CNY, while operating cash flow is 407.64 million CNY, indicating a healthy cash generation profile. Profitability metrics show a return on equity (ROE) of 8.85% and a return on assets (ROA) of 5.73%, both of which are in line with the industry's preferred metrics for healthcare services and equipment. The company's net income of 240.35 million CNY and operating income of 310.73 million CNY reflect a solid performance, though the gross profit margin of 32.9% suggests room for improvement in cost management. The company's revenue is not segmented by geographic region or product line in the available data, but its exposure is likely concentrated in the domestic Chinese market, as is typical for firms in this industry. No specific revenue concentration risks are disclosed, but the lack of geographic diversification could pose a risk in the event of regional economic downturns. Growth trajectory is not explicitly outlined in the data, but the company's free cash flow and operating cash flow suggest a stable financial position. The absence of recent growth metrics or outlooks makes it difficult to assess future performance, though the company's current financial health supports a neutral to positive outlook. Risk factors include a medium liquidity risk, with a current ratio of 1.77 and a negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no near-term pressure expected. However, the presence of long-term debt at 561.18 million CNY could become a concern if interest rates rise or if the company's cash flow generation weakens. Recent events and filings are not detailed in the available data, but the company's financial statements and risk assessment suggest a stable and conservative approach to capital management. No significant changes in strategy or operations are indicated in the latest financial snapshot.

30-day price · 603987-0.76 (-8.8%)
Low$7.90High$9.06Close$7.92As of15 May, 00:00 UTC
Profile
CompanyShanghai Kindly Enterprise Development Group Co Ltd
Ticker603987.SS
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Shanghai Kindly Enterprise Development Group Co Ltd operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to the market.

Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Shanghai Kindly Enterprise Development Group Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.21, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.77, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow stands at 190.76 million CNY, while operating cash flow is 407.64 million CNY, indicating a healthy cash generation profile. Profitability metrics show a return on equity (ROE) of 8.85% and a return on assets (ROA) of 5.73%, both of which are in line with the industry's preferred metrics for healthcare services and equipment. The company's net income of 240.35 million CNY and operating income of 310.73 million CNY reflect a solid performance, though the gross profit margin of 32.9% suggests room for improvement in cost management. The company's revenue is not segmented by geographic region or product line in the available data, but its exposure is likely concentrated in the domestic Chinese market, as is typical for firms in this industry. No specific revenue concentration risks are disclosed, but the lack of geographic diversification could pose a risk in the event of regional economic downturns. Growth trajectory is not explicitly outlined in the data, but the company's free cash flow and operating cash flow suggest a stable financial position. The absence of recent growth metrics or outlooks makes it difficult to assess future performance, though the company's current financial health supports a neutral to positive outlook. Risk factors include a medium liquidity risk, with a current ratio of 1.77 and a negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no near-term pressure expected. However, the presence of long-term debt at 561.18 million CNY could become a concern if interest rates rise or if the company's cash flow generation weakens. Recent events and filings are not detailed in the available data, but the company's financial statements and risk assessment suggest a stable and conservative approach to capital management. No significant changes in strategy or operations are indicated in the latest financial snapshot.
Key takeaways
  • The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.21.
  • Profitability metrics, including ROE of 8.85% and ROA of 5.73%, are in line with industry standards.
  • Free cash flow of 190.76 million CNY and operating cash flow of 407.64 million CNY indicate strong cash generation.
  • Liquidity is assessed as medium, with a current ratio of 1.77 and a negative net cash position after debt.
  • Dilution risk is low, with no near-term pressure expected.
  • The company's growth trajectory is not explicitly outlined, but its financial health supports a neutral to positive outlook.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.30B
Gross profit$756.0M
Operating income$310.7M
Net income$240.3M
R&D
SG&A
D&A
SBC
Operating cash flow$407.6M
CapEx-$146.6M
Free cash flow$190.8M
Total assets$4.19B
Total liabilities$1.48B
Total equity$2.72B
Cash & equivalents
Long-term debt$561.2M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.72B
Net cash-$561.2M
Current ratio1.8
Debt/Equity0.2
ROA5.7%
ROE8.8%
Cash conversion1.7%
CapEx/Revenue-6.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
Metric603987Activity
Op margin13.5%3.9% medp25 -31.3% · p75 14.4%above median
Net margin10.5%2.4% medp25 -30.5% · p75 11.1%above median
Gross margin32.9%46.7% medp25 28.2% · p75 63.1%below median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-6.4%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity21.0%17.9% medp25 2.7% · p75 52.2%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 22:32 UTC#da2c6706
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 01:05 UTCJob: 4009470c